443 related articles for article (PubMed ID: 17652392)
1. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
2. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus.
Negrete OA; Wolf MC; Aguilar HC; Enterlein S; Wang W; Mühlberger E; Su SV; Bertolotti-Ciarlet A; Flick R; Lee B
PLoS Pathog; 2006 Feb; 2(2):e7. PubMed ID: 16477309
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus.
Lee B; Pernet O; Ahmed AA; Zeltina A; Beaty SM; Bowden TA
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2156-65. PubMed ID: 25825759
[TBL] [Abstract][Full Text] [Related]
4. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
[TBL] [Abstract][Full Text] [Related]
7. Henipavirus membrane fusion and viral entry.
Aguilar HC; Iorio RM
Curr Top Microbiol Immunol; 2012; 359():79-94. PubMed ID: 22427111
[TBL] [Abstract][Full Text] [Related]
8. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model.
Guillaume V; Aslan H; Ainouze M; Guerbois M; Wild TF; Buckland R; Langedijk JP
J Virol; 2006 Aug; 80(15):7546-54. PubMed ID: 16840334
[TBL] [Abstract][Full Text] [Related]
10. Envelope-receptor interactions in Nipah virus pathobiology.
Lee B
Ann N Y Acad Sci; 2007 Apr; 1102(1):51-65. PubMed ID: 17470911
[TBL] [Abstract][Full Text] [Related]
11. Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding.
Bishop KA; Hickey AC; Khetawat D; Patch JR; Bossart KN; Zhu Z; Wang LF; Dimitrov DS; Broder CC
J Virol; 2008 Nov; 82(22):11398-409. PubMed ID: 18799571
[TBL] [Abstract][Full Text] [Related]
12. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.
Bishop KA; Stantchev TS; Hickey AC; Khetawat D; Bossart KN; Krasnoperov V; Gill P; Feng YR; Wang L; Eaton BT; Wang LF; Broder CC
J Virol; 2007 Jun; 81(11):5893-901. PubMed ID: 17376907
[TBL] [Abstract][Full Text] [Related]
13. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection.
Yuan J; Marsh G; Khetawat D; Broder CC; Wang LF; Shi Z
J Gen Virol; 2011 Sep; 92(Pt 9):2142-2152. PubMed ID: 21632558
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
16. Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivo.
Palomares K; Vigant F; Van Handel B; Pernet O; Chikere K; Hong P; Sherman SP; Patterson M; An DS; Lowry WE; Mikkola HK; Morizono K; Pyle AD; Lee B
J Virol; 2013 Feb; 87(4):2094-108. PubMed ID: 23192877
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus.
Laing ED; Navaratnarajah CK; Cheliout Da Silva S; Petzing SR; Xu Y; Sterling SL; Marsh GA; Wang LF; Amaya M; Nikolov DB; Cattaneo R; Broder CC; Xu K
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20707-20715. PubMed ID: 31548390
[TBL] [Abstract][Full Text] [Related]
18. Henipavirus receptor usage and tropism.
Pernet O; Wang YE; Lee B
Curr Top Microbiol Immunol; 2012; 359():59-78. PubMed ID: 22695915
[TBL] [Abstract][Full Text] [Related]
19. Expression, characterisation and antigenicity of a truncated Hendra virus attachment protein expressed in the protozoan host Leishmania tarentolae.
Fischer K; dos Reis VP; Finke S; Sauerhering L; Stroh E; Karger A; Maisner A; Groschup MH; Diederich S; Balkema-Buschmann A
J Virol Methods; 2016 Feb; 228():48-54. PubMed ID: 26585033
[TBL] [Abstract][Full Text] [Related]
20. A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F).
Aguilar HC; Ataman ZA; Aspericueta V; Fang AQ; Stroud M; Negrete OA; Kammerer RA; Lee B
J Biol Chem; 2009 Jan; 284(3):1628-35. PubMed ID: 19019819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
